CClinicalTrials.gg
CompletedNCT06623825SGINHZAGUpdated Oct 2, 2024

Smart Glasses in Emergency Medicine From the Hangzhou Asian Games

An observational study in Trauma Injury, Acute Coronary Syndrome and Stroke, Acute, sponsored by Sir Run Run Shaw Hospital. Completed at 1 site in China. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2024-10-02.

Sponsored by Sir Run Run Shaw Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
90
Ages
16 Years and older
Sex
All
01

Study summary

The findings of our study will reveal that using smart glasses in the emergency department(ED) could facilitate patient admission. AR Smart Glasses offer the potential to enhance the effectiveness and speed of treatment within ED.

Read the detailed description

Study Design:

This study will be conducted at Sir Run Run Shaw Hospital (SRRSH), China. This study aims to compare the outcomes of two groups: the intervention group, utilizing the Augmented Reality (AR) smart glasses, and the control group, adhering to the standard conventional triage process without the AR tool, only using a two-way radio connection.

Augmented Reality tool The AR tool used in this study will be a smart glasses manufactured by Rokid AR Studio(Hangzhou, China). It was Rokid glass 2 model released in 2020. The device operated on Android 9.0 and it connected to 5G connection with a bandwidth speed 30-mbps delivering a very low latency. The device supported real time screen sharing and therefore the data were collected from smart glasses including visual and audio with real-time two-way communications. Physicians at the hospital can access the information and video via a mobile app, enabling continuous monitoring of patients. The features facilitate healthcare providers at SRRSH and medical personnel in the HAG2022 polyclinic to discuss the patient's condition, exchange, and deliberate on the pre-hospital medical examinations of the patient.

Participants:

The study, will be conducted between September 13, 2023, and October 28, 2023, included the recruitment of all patients (older than 16 years old) presenting with acute illnesses who were admitted to the ED of SRRSH from the HAG2022 village polyclinic or the field of injury.

The Cases with incomplete data and cases where the patients would be not found will be excluded from this study. Cases involving technical difficulties encountered by operators using augmented reality (AR) smart glasses and loss of internet connection will be excluded from the study.

02

Conditions studied

  • Trauma Injury
  • Acute Coronary Syndrome
  • Stroke, Acute
  • Septic Shock

Keywords

  • Telemedicine
  • Tele-consultation
  • Smart glasses
  • Emergency Medicine
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 90 is below the median of 160 across 1,692 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Sir Run Run Shaw Hospital is the lead sponsor of 123 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Following the completion of the research period, there will be 80 patients categorized into the ARTS cohort consisting of 10 patients and the non-ARTS cohort comprising 70 patients. Gender and age demographics for ARTS and non-ARTS cohorts will be shown with no significant gender differences.

Inclusion criteria

  • Presenting with acute illnesses like acute coronary syndrome,acute sepsis,stroke,trauma who will be admitted to the ED of SRRSH from the HAG2022 village polyclinic or the field of injury.

Exclusion criteria

Exclusion Criteria:

  • The Cases with incomplete data and cases where the patients will be not found will be excluded from this study. Cases involving technical difficulties encountered by operators using augmented reality (AR) smart glasses and loss of internet connection will be excluded from the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
90 participants (actual)
Target follow-up
2 Months
Patient registry
Yes

Groups and cohorts

  • ARTS

    the teleconsultation by AR telemedicine system group

    Device: teleconsultation by Augmented Reality smart glasses

  • non-ARTS

    no teleconsultation by AR telemedicine system groups,but by the traditional methods like radios, telephonecalls

    Device: teleconsultation by two-way radio connection.

Interventions

  • Deviceteleconsultation by Augmented Reality smart glasses

    The device operated on Android 9.0 and it connected to 5G connection with a bandwidth speed 30-mbps delivering a very low latency. The device supported real time screen sharing and therefore the data were collected from smart glasses including visual and audio with real-time two-way communications. Physicians at the hospital can access the information and video via a mobile app, enabling continuous monitoring of patients. The features facilitate healthcare providers at SRRSH and medical personnel in the HAG2022 polyclinic to discuss the patient's condition, exchange, and deliberate on the pre-hospital medical examinations of the patient.

    Also known as: realtime teleconsultation by Augmented Reality smart glasses

  • Deviceteleconsultation by two-way radio connection.

    adhering to the standard conventional triage process without the AR tool, only using a two-way radio connection.

    Also known as: the traditional teleconsultation by two-way radio connection.

06

What researchers measure

Primary outcomes

  1. the consult response time (CRT)

    CRT refers to the duration from when consulting physicians are called to evaluate patients in the ED to their response

    Time frame: through study completion, an average of 1 year

  2. pre-preparation time (PPT )

    PPT refers to the duration required to prepare the patient for subsequent management

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Sir Run Run Shaw Hospital Zhejiang University School of Medicine
    Hangzhou, Zhejiang 310012, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06623825
Lead sponsor
Sir Run Run Shaw Hospital
Responsible party
Yucai Hong (Head of Emergency Department, Sir Run Run Shaw Hospital) — Principal investigator
First posted
Oct 2, 2024
Start date
Sep 27, 2023
Primary completion
Oct 30, 2023
Completion
Nov 20, 2023
Last update
Oct 2, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion